anon257072 Post 78 What are the differences between biology and science? I don't understand much about biology but I try to love it because my profession is in line with this. I find this subject a tough one, something complicated but I'm very willing to learn much. It is kind of boring, but it can be exciting and interesting in a while. Now, I'm planning to proceed in medicine so hope I will pick up biology easily. What is the usefulness of studying and knowing biology? I love biology and i want to learn more about biology. Looking forward to taking biology. I've never taken it before, just now finding out what it's all about! Looking forward to the challenge. --Anthony R., Long Beach, Ca well i am form 3 and till now i think that biology is an interesting subject. i will try my best in studying it but sometimes it gets so boring. as i grow up i want to be a vet. i love animals. thanks. i don't know much about biology but yes i know one thing if our having the will to do something new then try this. it can make our mind sharper. Read … Continue reading →

When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone-receptor positive disease, according to research from The University of Texas MD Anderson Cancer Center. The study findings defy the conventional belief that the two treatment interventions offer equal survival, and show the need to revisit some standards of breast cancer practice in the modern era. The research was presented at the 2014 Breast Cancer Symposium by Catherine Parker, MD, formerly a fellow at MD Anderson, now at the University of Alabama Birmingham. In the 1980s, both US-based and international randomized clinical studies found that BCT and mastectomy offered women with early stage breast cancer equal survival benefit. However, those findings come from a period in time when very little was understood about breast cancer biology, explains Isabelle Bedrosian, M.D., associate professor, surgical oncology at MD Anderson. "Forty years ago, very little was known about breast cancer disease biology -- such as subtypes, differences in radio-sensitivities, radio-resistances, local recurrence and in metastatic potential," explains Bedrosian, the study's senior author. "Since then, there's been a whole body of biology that's been … Continue reading →

PUBLIC RELEASE DATE: 4-Sep-2014 Contact: Laura Sussman lsussman@mdanderson.org 713-745-2457 University of Texas M. D. Anderson Cancer Center When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone-receptor positive disease, according to research from The University of Texas MD Anderson Cancer Center. The study findings defy the conventional belief that the two treatment interventions offer equal survival, and show the need to revisit some standards of breast cancer practice in the modern era. The research was presented at the 2014 Breast Cancer Symposium by Catherine Parker, MD, formerly a fellow at MD Anderson, now at the University of Alabama Birmingham. In the 1980s, both US-based and international randomized clinical studies found that BCT and mastectomy offered women with early stage breast cancer equal survival benefit. However, those findings come from a period in time when very little was understood about breast cancer biology, explains Isabelle Bedrosian, M.D., associate professor, surgical oncology at MD Anderson. "Forty years ago, very little was known about breast cancer disease biology such as subtypes, differences in radio-sensitivities, radio-resistances, local recurrence and in metastatic potential," explains … Continue reading →